Beyond the estrogen receptor: In search of predictive biomarkers for low-grade serous ovarian cancer

Cancer. 2023 May 1;129(9):1305-1307. doi: 10.1002/cncr.34658. Epub 2023 Mar 3.

Authors

Rachel N Grisham¹, Beryl L Manning-Geist², M Herman Chui³

Affiliations

¹ Department of Medicine, Memorial Sloan Kettering Cancer Center and Weill Cornell Medical College, New York, New York, USA.
² Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
³ Department of Pathology and Laboratory Medicine, Memorial Sloan Kettering Cancer Center, New York, New York, USA.

PMID: 36867575
DOI: 10.1002/cncr.34658

No abstract available

Publication types

Research Support, N.I.H., Extramural

MeSH terms

Biomarkers
Biomarkers, Tumor
Cystadenocarcinoma, Serous* / genetics
Female
Humans
Ovarian Neoplasms* / diagnosis
Ovarian Neoplasms* / genetics
Receptors, Estrogen

Substances

Receptors, Estrogen
Biomarkers
Biomarkers, Tumor